Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jarrett J. Failing
Observed names:
Jarrett Failing,
Jarrett J Failing
Observed institutions:
Mayo Clinic,
Mayo Clinic Comprehensive Cancer Center (Minnesota),
North Dakota State University
OpenAlex ID:
A5069748645
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma
2016
·
Jarrett J. Failing
, Heidi D. Finnes
, et al.
·
Melanoma Research
·
58
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
2020
·
Jesus Vera Aguilera
, Jonas Paludo
, et al.
·
Melanoma Research
·
51
Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients
2017
·
Jarrett J. Failing
, Yiyi Yan
, et al.
·
Melanoma Research
·
46
Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab
2020
·
Jarrett J. Failing
, Thanh P. Ho
, et al.
·
JCO Oncology Practice
·
45
Biomarkers of Hyperprogression and Pseudoprogression with Immune Checkpoint Inhibitor Therapy
2019
·
Jarrett J Failing
, Olivia A Dudek
, et al.
·
Future Oncology
·
18
Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer
2020
·
Jarrett J. Failing
, Marie Christine Aubry
, et al.
·
Cancer Immunology Immunotherapy
·
14
Florid dermatopathic lymphadenopathy—A morphological mimic of Langerhans cell histiocytosis
2018
·
Aishwarya Ravindran
, Gaurav Goyal
, et al.
·
Clinical Case Reports
·
11
PDF
Chemoimmunotherapy combination after PD-1 inhibitor failure to improve clinical outcomes in metastatic melanoma patients.
2018
·
Jesus Vera Aguilera
, Jonas Paludo
, et al.
·
Journal of Clinical Oncology
·
8
Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis
2011
·
Emilie E. Vomhof-DeKrey
, Ashley R. Sandy
, et al.
·
Peptides
·
8
The Mayo Clinic experience in patients with metastatic melanoma who have failed previous pembrolizumab treatment.
2016
·
Yiyi Yan
, Jarrett Failing
, et al.
·
Journal of Clinical Oncology
·
6
Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry
2011
·
Rebecca J. Hermann
, Travis Van der Steen
, et al.
·
Journal of Immunological Methods
·
5
Human leukocyte antigen expression in paired primary lung lesions and brain metastases in non-small cell lung cancer.
2020
·
Jarrett Failing
, Marie-Christine Aubry
, et al.
·
Journal of Clinical Oncology
·
2
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.
2016
·
Jarrett Failing
, Heidi D. Finnes
, et al.
·
Journal of Clinical Oncology
·
2
Altered Mental Status After Hematopoietic Stem Cell Transplant
2021
·
Jarrett J. Failing
, Omar M. Abu Saleh
, et al.
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients.
2019
·
Jesus Vera Aguilera
, Jonas Paludo
, et al.
·
Journal of Clinical Oncology
61-Year-Old Man With Hypercalcemia and Generalized Lymphadenopathy
2016
·
Ashley M. Egan
, Jarrett J. Failing
, et al.
·
Mayo Clinic Proceedings
35-Year-Old Man With Thrombocytopenia and Generalized Lymphadenopathy
2015
·
Jarrett J. Failing
, John V. Higgins
, et al.
·
Mayo Clinic Proceedings
PDF
Neuropeptides and Colon Cancer; Another Notch in the Complexity of Tumorigenesis
2010
·
Naomi G Light
, Keith D Benton
, et al.
·
The FASEB Journal
Ikaros engages the VPAC1 promoter and recruits HDAC1 in activated HuT78 cells
2010
·
Keith D Benton
, Rebecca J Hermann
, et al.
·
The FASEB Journal
Can neuropeptide receptors really cause leukemogenesis
2010
·
Jarrett Failing
, Sheri Dorsam
, et al.
·
The FASEB Journal
Vasoactive intestinal peptide induces apoptosis in naïve but not in activated HuT 78 cells
2009
·
Jarrett Failing
, Sheri Dorsam
, et al.
·
The FASEB Journal
The five transmembrane vasoactive intestinal peptide receptor 1 isoform is expressed in human blood CD14+ monocyte cells
2009
·
Rebecca J Hermann
, Travis Van der Steen
, et al.
·
The FASEB Journal
The tumor suppressor Ikaros transcription factor is crucial for the anti‐proliferative Vasoactive Intestinal Peptide Receptor‐1 expression in developing thymocytes
2008
·
Ashley Rose Sandy
, Jarrett Failing
, et al.
·
The FASEB Journal
Show more works
View as search
Works count:
23
Citation count:
274
H-index:
8
I10-index:
7
Year
Topic
Type